Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New concepts of coagulation and bleeding in liver disease.

Literature DB >> 20082189

New concepts of coagulation and bleeding in liver disease.

Patrick G Northup¹, Stephen H Caldwell.

Abstract

Entities: Disease

Mesh：

Year: 2010 PMID： 20082189 DOI： 10.1007/s11739-009-0345-1

Source DB: PubMed Journal: Intern Emerg Med ISSN： 1828-0447 Impact factor: 3.397

× No keyword cloud information.

21 in total

1. Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy.

Authors: Andrew Y C Wong; Michael G Irwin; Theresa W C Hui; Serena K Y Fung; S T Fan; Edmond S K Ma
Journal: Can J Anaesth Date: 2003-01 Impact factor: 5.063

2. The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis.

Authors: B Gunawan; B Runyon
Journal: Aliment Pharmacol Ther Date: 2006-01-01 Impact factor: 8.171

3. No evidence for an intrinsic platelet defect in patients with liver cirrhosis--studies under flow conditions.

Authors: T Lisman; J Adelmeijer; P G de Groot; H L A Janssen; F W G Leebeek
Journal: J Thromb Haemost Date: 2006-07-12 Impact factor: 5.824

4. Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.

Authors: S Basili; D Ferro; R Leo; L Juliano; C Alessandri; C Cordova; F Violi
Journal: J Hepatol Date: 1996-05 Impact factor: 25.083

5. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.

Authors: K Q Hu; A S Yu; L Tiyyagura; A G Redeker; T B Reynolds
Journal: Am J Gastroenterol Date: 2001-05 Impact factor: 10.864

6. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.

Authors: Patrick G Northup; Matthew M McMahon; A Parker Ruhl; Scott E Altschuler; Agata Volk-Bednarz; Stephen H Caldwell; Carl L Berg
Journal: Am J Gastroenterol Date: 2006-07 Impact factor: 10.864

Review 7. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

Authors: Ian R Wanless; Koji Shiota
Journal: Semin Liver Dis Date: 2004-02 Impact factor: 6.115

New concepts of coagulation and bleeding in liver disease.

1. Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy.

2. The efficacy and safety of epsilon-aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis.

3. No evidence for an intrinsic platelet defect in patients with liver cirrhosis--studies under flow conditions.

4. Bleeding time does not predict gastrointestinal bleeding in patients with cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.

5. Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.

6. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.

Review 7. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis.

Review 8. Abnormalities of hemostasis and bleeding in chronic liver disease: the paradigm is challenged.

9. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis.

Review 10. Hypercoagulation and thrombophilia in liver disease.

1. Abdominal infection reveals a rare disease.

Review 2. Management of thrombocytopenia due to liver cirrhosis: a review.

Review 3. The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting.